• Turning up the heat on nano research

    Scientists from the University of Surrey have developed nanoparticles that heat up to a temperature high enough to kill cancerous cells. They also cleverly self-regulate to cool down before they...

  • Is a universal flu vaccine on the horizon?

    Oxford University spin-out company Vaccitech is trialling what it hopes will be a more effective, universal flu vaccine. The company recently raised £20m from investors including Google parent firm Alphabet,...

  • Cracking the mysteries of Alzheimer’s disease

    With Pfizer shutting down its neuroscience unit and a long list of failed late-stage trials, the sheer difficulty of improving the treatment of Alzheimer’s disease has become painfully clear. How...

  • Pharma Technology Focus – Issue 68

    In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells,...

  • Using mRNa to target tumours

    Eli Lilly recently announced it is investing $1.8bn in a project with CureVac to develop mRNA cancer vaccines. While their work is still at an early stage, research suggests that...

  • Breaking cancer’s drug addiction

    Cancer cells can become addicted to the drugs designed to kill them, and now a group of scientists from the Netherlands Cancer Institute has discovered the underlying mechanism. Abi Millar...

  • Could MDMA become psychiatry’s antibiotic?

    MDMA has been achieving impressive results as an experimental treatment for post-traumatic stress disorder (PTSD). Elly Earls finds out why its approval could mark the beginning of a new era...